Literature DB >> 18524984

Postoperative spinal wound infections.

Rick C Sasso1, Ben J Garrido.   

Abstract

Surgical site infection is a common adverse event and a significant source of morbidity after any spinal procedure. A patient who presents with postoperative infection often requires prolonged hospitalization, revision surgical procedures, and long-term intravenous antibiotics. Awareness of risk factors and preventive measures can lead to improved outcomes. Infection after spinal surgery may pose diagnostic challenges and difficult management questions. Postoperative spinal infections present with a diverse degree of severity, from superficial skin incision infections to deep subfascial infections with myonecrosis. Definitive management is based on etiology, clinical course, and patient risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18524984     DOI: 10.5435/00124635-200806000-00005

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  33 in total

1.  Individualized antibiotic prophylaxis reduces surgical site infections by gram-negative bacteria in instrumented spinal surgery.

Authors:  Susana Núñez-Pereira; F Pellisé; D Rodríguez-Pardo; C Pigrau; J M Sánchez; J Bagó; C Villanueva; E Cáceres
Journal:  Eur Spine J       Date:  2011-07-26       Impact factor: 3.134

Review 2.  A methodological, systematic review of evidence-based independent risk factors for surgical site infections after spinal surgery.

Authors:  Dan Xing; Jian-Xiong Ma; Xin-Long Ma; Dong-Hui Song; Jie Wang; Yang Chen; Yang Yang; Shao-Wen Zhu; Bao-Yi Ma; Rui Feng
Journal:  Eur Spine J       Date:  2012-09-22       Impact factor: 3.134

3.  Risk factors for deep surgical site infections after spinal fusion.

Authors:  J J P Schimmel; P P Horsting; M de Kleuver; G Wonders; J van Limbeek
Journal:  Eur Spine J       Date:  2010-05-06       Impact factor: 3.134

4.  Capacitive coupling reduces instrumentation-related infection in rabbit spines: a pilot study.

Authors:  Mohit Gilotra; Cullen Griffith; Jason Schiavone; Naren Nimmagadda; Jenna Noveau; Steven C Ludwig
Journal:  Clin Orthop Relat Res       Date:  2012-06       Impact factor: 4.176

5.  Do Longer Surgical Procedures Result in Greater Contamination of Surgeons' Hands?

Authors:  Pooria Hosseini; Gregory M Mundis; Robert Eastlack; Allen Nourian; Jeff Pawelek; Stacie Nguyen; Behrooz A Akbarnia
Journal:  Clin Orthop Relat Res       Date:  2016-04-18       Impact factor: 4.176

Review 6.  [Management of postoperative wound infections following spine surgery : First results of a multicenter study].

Authors:  M Rickert; P Schleicher; C Fleege; M Arabmotlagh; M Rauschmann; F Geiger; K J Schnake
Journal:  Orthopade       Date:  2016-09       Impact factor: 1.087

7.  Risk factors for implant removal after spinal surgical site infection.

Authors:  Naoya Tsubouchi; Shunsuke Fujibayashi; Bungo Otsuki; Masanori Izeki; Hiroaki Kimura; Masato Ota; Takeshi Sakamoto; Akira Uchikoshi; Shuichi Matsuda
Journal:  Eur Spine J       Date:  2017-09-14       Impact factor: 3.134

8.  A review of the application of vancomycin powder to posterior spinal fusion wounds with a focus on side effects and infection. A prospective study.

Authors:  Evelyn P Murphy; Mark Curtin; Aseer Shafqat; Fergus Byrne; Mutaz Jadaan; Elias Rahall
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-11-17

9.  Reoperation within 2 years after lumbar interbody fusion: a multicenter study.

Authors:  Kazuyoshi Kobayashi; Kei Ando; Fumihiko Kato; Tokumi Kanemura; Koji Sato; Yudo Hachiya; Yuji Matsubara; Mitsuhiro Kamiya; Yoshihito Sakai; Hideki Yagi; Ryuichi Shinjo; Yoshihiro Nishida; Naoki Ishiguro; Shiro Imagama
Journal:  Eur Spine J       Date:  2018-02-08       Impact factor: 3.134

10.  Postoperative changes of early-phase inflammatory indices after uncomplicated anterior cervical discectomy and fusion using allograft and demineralised bone matrix.

Authors:  Chae-Gwan Kong; Young-Yul Kim; Jong-Beom Park
Journal:  Int Orthop       Date:  2012-08-24       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.